Funding Opportunity RFA-DK-20-507 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the current USDRN Scientific Data Research Center to complete these clinical investigations.

Notice NOT-CA-20-100 from the NIH Guide for Grants and Contracts

Notice NOT-TW-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-172 from the NIH Guide for Grants and Contracts

Notice NOT-OH-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-103 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-293 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations; (2) organizing and delivering optimized mental health services within real world treatment settings; and (3) continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems. The ALACRITY Centers program is intended to support research that maximizes synergies across various components of the mental health research ecosystem, including new discoveries in clinical research, transformative health care technologies, advances in information science, and new federal and state mechanisms for organizing mental health care.

Notice NOT-CA-20-102 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-170 from the NIH Guide for Grants and Contracts

Notice NOT-MD-20-029 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-073 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-072 from the NIH Guide for Grants and Contracts

Notice NOT-AG-20-034 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-047 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-296 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. Specifically, this FOA will support the development of exportable training modules designed to enhance training of the biomedical research workforce.o

Notice NOT-HL-20-737 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-104 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-298 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to understand the contribution of specific elements of maternal molecular and cellular factors that can control and effect the development of the fetal immune system.

Notice NOT-NS-20-005 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-080 from the NIH Guide for Grants and Contracts